⌘+K

Pulse Explore Clubs Researchers Journals

Home Clubs Explore

February 28, 2024Journal of Comparative Effectiveness ResearchOpen Access

Early-stage hepatocellular carcinoma screening in patients with chronic hepatitis B in China: a cost–effectiveness analysis

Yuemin Nan Osvaldo Ulises Garay X. Lu Yue Zhang Li Xie Zhongyi Niu Wen Chen

View Full Paper

Ask AI

Bookmark

Share

Abstract

To evaluate the cost-effectiveness of seven screening strategies for chronic hepatitis B (CHB) patients in China.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Nan et al. (2024) studied this question.

synapsesocial.com/papers/68e7720db6db6435876e730e https://doi.org/10.57264/cer-2023-0146

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Universal screening and treatment towards the elimination of chronic hepatitis C in China: an economic evaluation2024 · 6 citations
2[Cost-effectiveness of HCV testing strategies for hepatitis C elimination in general population in China].2024
3Economic evaluation of hepatocellular carcinoma surveillance in chronic hepatitis B patients with virological remission2024 · 1 citations
4Cost‐Effectiveness of Interventions to Improve Retention in Care for Chronic Hepatitis B in the United StatesCost-Effectiveness Analysis · 2026
5Reassessing the Baveno based strategy in China: a cost-effectiveness analysis of screening for high-risk varices in cirrhosisOriginal Research · 2026